Cetuximab is one of the clearer examples in oncology of precision medicine in practice — its effectiveness depends entirely on the genetic makeup of a patient's tumor, specifically the RAS gene status, and prescribing it without that confirmation is both clinically inappropriate and a genuine risk of treatment failure. It works by blocking EGFR, a receptor that many colorectal and head & neck cancers rely on for growth signaling, but only in tumors where the downstream RAS pathway hasn't independently mutated to bypass EGFR blockade entirely.

• Approved indications: Metastatic colorectal cancer (RAS wild-type tumors only), locally advanced or recurrent/metastatic head and neck squamous cell carcinoma
• Mechanism: Binds and blocks EGFR (epidermal growth factor receptor), interrupting growth-signaling pathways cancer cells depend on
• Critical prescribing requirement: RAS mutation testing is mandatory before initiating treatment for colorectal cancer — RAS-mutant tumors show no clinical benefit and combining Cetuximab with oxaliplatin-based chemotherapy in this population is specifically contraindicated due to worse outcomes observed in trials
• Combination therapy: Typically combined with chemotherapy (FOLFIRI regimens in colorectal cancer) or radiation therapy (in head and neck cancer)

• Biomarker prerequisite: RAS wild-type status must be confirmed via tumor genetic testing before treatment — this is a hard clinical requirement, not a recommendation, and distributors should confirm the receiving facility has access to this testing before finalizing large orders
• Infusion reactions: Can range from mild to severe (including anaphylaxis); pre-medication and close monitoring during the first infusion are standard practice
• Interstitial lung disease: Rare but serious risk requiring immediate discontinuation if respiratory symptoms develop
• Dermatologic toxicity: Acneiform skin rash is a very common side effect, generally correlated with treatment response but requiring proactive management
• Restrictions: Not established for use in children; not recommended in pregnancy

Stock status: Available per shipment, standard lead time

• Logistics: GDP-compliant cold-chain export (2–8°C)
• Coverage: Global export markets
• Tracking: Full shipment tracking included

What is Cetuximab used for?

Treats metastatic colorectal cancer (RAS wild-type only) and head & neck squamous cell cancer.

Get Cetuximab price from a GMP-compliant Indian supplier — how?

Send required quantity and destination for a quote.

Does it work for all colorectal cancer patients?

No, only RAS wild-type tumors respond — genetic testing confirmation is required before treatment.

Can it be combined with chemo?

Yes, commonly combined with chemotherapy or radiation, though not with oxaliplatin-based regimens in RAS-mutant tumors.

Who exports Cetuximab from India?

WHO-GMP certified supplier with full documentation.